-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Reiterates Sector Perform on Regeneron Pharmaceuticals, Maintains $737 Price Target

Benzinga·09/29/2026 12:35:13
Listen to the news
RBC Capital analyst Brian Abrahams reiterates Regeneron Pharmaceuticals (NASDAQ:REGN) with a Sector Perform and maintains $737 price target.